Sharma et al re-weighted the coefficients used in the Model for End-Stage Liver Disease (MELD) score. The authors are from the University of Michigan and the Arbor Research Collaborative for Health.
Patient selection: end-stage liver disease
Parameters:
(1) serum creatinine in mg/dL
(2) serum total bilirubin in mg/dL
(3) INR
In the original MELD score the variables had upper and lower bounds. The updated MELD score uses unbounded variables (page 1576).